Colella, FabioGarcia, João PedroSorbona, MarcoLolli, AndreaAntunes, BernardoD'Atri, DomenicoBarré, Florian P.Y.Oieni, JacopoVainieri, Maria LetiziaZerrillo, LuanaCapar, SerdarHäckel, SonjaCai, YunpengCreemers, Laura B.2020-10-152020-10-152020-12-10Colella, F, Garcia, J P, Sorbona, M, Lolli, A, Antunes, B, D'Atri, D, Barré, F P Y, Oieni, J, Vainieri, M L, Zerrillo, L, Capar, S, Häckel, S, Cai, Y & Creemers, L B 2020, 'Drug delivery in intervertebral disc degeneration and osteoarthritis : Selecting the optimal platform for the delivery of disease-modifying agents', Journal of Controlled Release, vol. 328, pp. 985-999. https://doi.org/10.1016/j.jconrel.2020.08.0410168-3659https://hdl.handle.net/2164/15232Acknowledgement We would like to acknowledge Prof. Gerjo Van Osch and prof Molly Stevens for their careful and critical revision of the manuscript. We wish to thank all principal investigators of the TargetCaRe consortium for their enormous support during the years: Prof G. van Osch. Prof. Mauro Alini, Prof. Bruce Caterson, Dr. Alan Chan, Prof. Cosimo De Bari, Prof. Ron Heeren, Prof. Kennet Howard, Prof. Marcelle Machluf, Prof. Molly M. Stevens and Prof. Avner Yayon. This work was supported by European Union's Horizon 2020 Research And Innovation Programme under Marie Sklodowska Curie Grant agreement no. 642414.1530141752996946engR MedicinePharmaceutical ScienceRJournal item10.1016/j.jconrel.2020.08.041http://www.scopus.com/inward/record.url?scp=85090558186&partnerID=8YFLogxK328